Aspirin plus tirofiban inhibit the thrombosis induced by Russell's viper venom. Issue 1 (October 2016)

• Record Type: Journal Article
• Authors: Wu, Ren-Chieh; Chou, Ping-Tse; Chen, Li-Kuang
• Is Part Of: Thrombosis journal. Volume 14:Issue 1(2016)
• Page Start: 9
• Page End: 16
• Publication Date: 2016-10
• Subjects: Russell's viper venom -- Mouse model -- Thrombosis -- Antiplatelet; Thrombosis -- Periodicals; 616.135005
• DOI: 10.1186/s12959-016-0093-1
• Languages: English
• ISSNs: 1477-9560

Abstract

Abstract Background Thrombosis and coagulopathy are the commonest hematological manifestations of envenomation of Russell's viper venom (RVV). Factor X is activated by a factor X-activating enzyme from Russell's viper venom (RVV-X) to start the coagulation cascade. We established an animal model with local ischemic effects induced by RVV. We tried to treat RVV envenomation with antiplatelets and anticoagulants without recourse to antivenom. Methods RVV was injected into the foot pad of mice. We observed the effects at different intervals and compared local changes in ischemia with drug treatment after 30 min. Results A combination of aspirin plus tirofiban could prevent the ischemic change induced by RVV. The antithrombotic effects of single-use of aspirin or tirofiban were better than single-use of heparin or clopidogrel. Conclusion The aspirin + tirofiban group had a better outcome with respect to prevention of tissue ischemia and gangrene. This indicates that the activation and aggregation of platelets is the major cause of thrombosis induced by RVV.